Autologous Cultured Chondrocytes

CHEMBL5315092 Phase 4 Aprovado Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

Living cartilage cells harvested from a patient's own joint, grown and multiplied in the laboratory, and then re-implanted into a damaged area of cartilage to promote natural repair. This cell therapy is used for focal cartilage defects in the knee.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Living cartilage cells harvested from a patient's own joint, grown and multiplied in the laboratory, and then re-implanted into a damaged area of cartilage to promote natural repair. This cell therapy is used for focal cartilage defects in the knee.

Yes, Autologous Cultured Chondrocytes is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315092. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Procura informações acessíveis para o paciente?

Autologous Cultured Chondrocytes no PillFYI

Dados Rápidos

Sinônimos: 2

Links Externos

ChEMBL CHEMBL5315092

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.